ChemicalBook > CAS DataBase List > GalliuM Maltolate

GalliuM Maltolate

Product Name
GalliuM Maltolate
CAS No.
108560-70-9
Chemical Name
GalliuM Maltolate
Synonyms
Gallixa;GalliuM Maltolate;Gallium maltolate (Gallixa);GALLIUM MALTOLATE(108560-70-9);Gallium tris(2-methyl-4-oxo-4H-pyran-3-olate);Tris[3-(hydroxy-κO)-2-Methyl-4H-pyran-4-onato-κO4]galliuM;Tris[3-(hydroxy-kappaO)-2-Methyl-4H-pyran-4-onato-kappaO4]galliuM
CBNumber
CB92648757
Molecular Formula
C18H9GaO15
Formula Weight
534.97806
MOL File
108560-70-9.mol
More
Less

GalliuM Maltolate Property

form 
Solid
color 
Off-white to light yellow
InChI
InChI=1S/3C6H4O5.Ga/c3*7-3-1-2-11-5(4(3)8)6(9)10;/h3*1-2,8H,(H,9,10);/q;;;+3/p-3
InChIKey
LRPKBZSTANNRLK-UHFFFAOYSA-K
SMILES
[Ga+3].O1C(C([O-])=O)=C(O)C(=O)C=C1.O1C(C([O-])=O)=C(O)C(=O)C=C1.O1C(C([O-])=O)=C(O)C(=O)C=C1
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
COS0000536
Product name
GALLIUM MALTOLATE
Purity
95.00%
Packaging
5MG
Price
$501.02
Updated
2021/12/16
More
Less

GalliuM Maltolate Chemical Properties,Usage,Production

Description

Gallium maltolate (GaM) is a new orally administered compound that has the potential to fundamentally improve the lives of many of these patients by providing effective treatment without serious side effects. GaM is being developed as an orally active formulation of gallium, a drug already approved by the FDA in intravenous form (gallium nitrate for injection). Clinical and preclinical studies have repeatedly shown gallium to have efficacy against cancer, inflammatory disorders, infectious disease, and bone loss.

Biological Activity

Gallium maltolate is a ribonucleoside-diphosphate reductase inhibitor potentially for the treatment of prostate cancer.

Clinical Use

Gallium maltolate has been administered to healthy volunteers and to some late-stage cancer patients in Phase I clinical trials. It has been given at doses as high as 3,500 mg/day for multiple 28-day cycles, with no dose-limiting toxicity or serious drug-related adverse effects. The compound has shown high oral bioavailability with an elimination half-life of approximately 17 to 21 hours. Anecdotal efficacy has been observed in patients with lymphoma, end-stage liver cancer (hepatocellular carcinoma), metastatic prostate cancer, metastatic colon cancer, metastatic lung cancer, and metastatic breast cancer.

Structure and conformation

Gallium maltolate, tris(3-hydroxy-2-methyl-4-pyronato)gallium, is a coordination complex consisting of a gallium atom surrounded by three maltolate ligands. Gallium maltolate is electrically neutral and moderately soluble in both water and lipids. It is stable over a pH range of approximately 5 through 8, a relatively large interval for a metal-organic complex.

GalliuM Maltolate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GalliuM Maltolate Suppliers

R&D Scientific Inc.
Tel
+1-2266000236
Email
sales@rdscientific.com
Country
Canada
ProdList
1627
Advantage
58
More
Less

View Lastest Price from GalliuM Maltolate manufacturers

Watson Biotechnology Co.,Ltd
Product
GalliuM Maltolate 108560-70-9
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20MT
Release date
2024-08-16

108560-70-9, GalliuM MaltolateRelated Search:


  • GalliuM Maltolate
  • Tris[3-(hydroxy-kappaO)-2-Methyl-4H-pyran-4-onato-kappaO4]galliuM
  • Tris[3-(hydroxy-κO)-2-Methyl-4H-pyran-4-onato-κO4]galliuM
  • Gallium maltolate (Gallixa)
  • Gallixa
  • Gallium tris(2-methyl-4-oxo-4H-pyran-3-olate)
  • GALLIUM MALTOLATE(108560-70-9)
  • 108560-70-9
  • C18H15GaO9